Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 11;70(23):858-864.
doi: 10.15585/mmwr.mm7023e2.

Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021

Affiliations

Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021

Athalia Christie et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Throughout the COVID-19 pandemic, older U.S. adults have been at increased risk for severe COVID-19-associated illness and death (1). On December 14, 2020, the United States began a nationwide vaccination campaign after the Food and Drug Administration's Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine. The Advisory Committee on Immunization Practices (ACIP) recommended prioritizing health care personnel and residents of long-term care facilities, followed by essential workers and persons at risk for severe illness, including adults aged ≥65 years, in the early phases of the vaccination program (2). By May 1, 2021, 82%, 63%, and 42% of persons aged ≥65, 50-64, and 18-49 years, respectively, had received ≥1 COVID-19 vaccine dose. CDC calculated the rates of COVID-19 cases, emergency department (ED) visits, hospital admissions, and deaths by age group during November 29-December 12, 2020 (prevaccine) and April 18-May 1, 2021. The rate ratios comparing the oldest age groups (≥70 years for hospital admissions; ≥65 years for other measures) with adults aged 18-49 years were 40%, 59%, 65%, and 66% lower, respectively, in the latter period. These differential declines are likely due, in part, to higher COVID-19 vaccination coverage among older adults, highlighting the potential benefits of rapidly increasing vaccination coverage.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Average daily number of total COVID-19 vaccine doses administered and cumulative percentage of adults aged ≥18 years who received ≥1 dose and who were fully vaccinated, by age group — United States, December 14, 2020–May 1, 2021 * Based on 7-day moving average. Age was unknown for 8% of fully vaccinated persons. § Texas does not report demographic-specific dose number information to CDC, so data for Texas are not represented in cumulative percentage of population vaccinated.
FIGURE 2
FIGURE 2
Weekly COVID-19 rates (A),,, emergency department visits for patients with a diagnosis of COVID-19 (B), hospital admissions with confirmed COVID-19 diagnosis (C),, and COVID-19 deaths (D), among adults, by age group, and rate ratio for persons aged ≥65 or ≥70 years versus 18–49 years — United States, September 6, 2020–May 1, 2021 Sources: CDC’s case-based COVID-19 surveillance system, accessed May 26, 2021 (A); National Syndromic Surveillance Program, accessed May 26, 2021 (B); U.S. Department of Health and Human Services Unified Hospital dataset, accessed May 26, 2021 (C); National Vital Statistics System, accessed May 26, 2021 (D). Abbreviation: ED = emergency department. * COVID-19 cases per 100,000 persons. Case classifications for COVID-19 are described in https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2020-08-05 and https://www.cdc.gov/ coronavirus/2019-ncov/covid-data/faq-surveillance.html. § Demographic data are based on a subset of COVID-19 cases for whom case-level data have been reported by state and territorial jurisdictions, accounting for approximately 80% of all cases reported to CDC. Patient age was unknown for 0.7% of cases. ED visits are shown as visits for patients with a diagnosis of COVID-19 per 100,000 ED visits reported. ED visits for patients with a diagnosis of COVID-19 are defined as ED visits with any of the following: International Classification of Diseases, Tenth Revision codes U07.1 or J12.82 or Systematized Nomenclature of Medicine 840539006, 840544004, or 840533007. Patient age was unknown for 0.4% of ED visits. ** Hospital admissions with confirmed COVID-19 diagnosis per 100,000 persons. †† Dataset includes data reported by hospitals registered with the Centers for Medicare & Medicaid Services. Data were reported to the U.S. Department of Health and Human Services directly from facilities or via a state submission; on May 1, 2021, 98.5% of hospitals reported. This analysis includes Veterans Administration, Defense Health Agency, and Indian Health Services hospitals and excludes psychiatric, rehabilitation, and religious nonmedical hospitals. Patient age was unknown for 4% of hospital admissions. §§ COVID-19 deaths per 100,000 persons. ¶¶ Deaths with confirmed or presumed COVID-19 as an underlying or contributing cause of death, with International Classification of Diseases, Tenth Revision code U07.1. Provisional data are incomplete. Decedent age was unknown for <0.01% of deaths.

References

    1. Bialek S, Boundy E, Bowen V, et al.; CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343–6. 10.15585/mmwr.mm6912e2 - DOI - PMC - PubMed
    1. Dooling K, Marin M, Wallace M, et al. The Advisory Committee on Immunization Practices’ updated interim recommendation for allocation of COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep 2021;69:1657–60. 10.15585/mmwr.mm695152e2 - DOI - PMC - PubMed
    1. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986;1:54–75. 10.1214/ss/1177013815 - DOI
    1. Rinott E, Youngster I, Lewis YE. Reduction in COVID-19 patients requiring mechanical ventilation following implementation of a national COVID-19 vaccination program—Israel, December 2020–February 2021. MMWR Morb Mortal Wkly Rep 2021;70:326–8. 10.15585/mmwr.mm7009e3 - DOI - PMC - PubMed
    1. Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021;397:1819–29. 10.1016/S0140-6736(21)00947-8 - DOI - PMC - PubMed

Substances